Catalase expression is also inhibited by miR-551b in human lung cancer cells and the miR-551b/CAT pathway can be involved in acquired apoptosis resistance and chemoresistance through interaction with MUC1 [115]. This evidence concerns the gene CAT and lung carcinoma.